New drug listings for reimbursement in New Zealand

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.352, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CNS drugs prominent in NZ's Q2 new drug listings

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 317, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Waiting for Reimbursement of New Medicines in Canada: It's Time for a Rethink

By Skinner Brett J.

PharmacoEconomics, Vol. 26, Iss. 8, 2008-01 ,pp. : 629-632

Adis International

Access to resources Recommend Favorite

Six new drugs on Finland's special reimbursement list

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Drug Use Evaluation Services in Australia and New Zealand: a Neglected Area of Research?

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 1, 2010-03 ,pp. : 15-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

The national reimbursement list in Hungary expanded by 126 new medicines in April

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 477, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite